2-es típusú cukorbetegség: vizsgálatok itt: Kanada
68 of 81 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in KanadaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Brampton, Calgary, Halifax, Kelowna, Montreal, Pointe-Claire, Québec, St. John's, Terrebonne, Waterloo
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleA Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Where
- Brampton, Concord, Montreal, Nepean, New Westminster, Québec, Toronto
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07754461 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Calgary, Cambridge, Chicoutimi, Courtice, Halifax, Joliette, Kelowna, Laval, London, Mississauga, Moncton, Montreal, Newmarket, New Westminster, North Vancouver, Oshawa, Ottawa, Penticton, Peterborough, Québec, Red Deer, Saint-Lambert, Sarnia, Scarborough Village, Sherbrooke, Stoney Creek, Stouffville, Surrey, Terrebonne, Toronto, Trois-Rivières
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisNot yet taking people in KanadaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Brampton, Etobicoke, Moncton, Montreal, Québec, Surrey
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - No phaseTaking peopleAcute Blood Flow Restriction Walking on Immune Cell Phenotype and Function
- Where
- Kelowna
- Életkor
- 19 év to 64 év
- People
- 20
- Run by
- University of British Columbia
See details and how to joinNCT07928531 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Brampton, Calgary, Hamilton, Québec, Sarnia, Surrey, Trois-Rivières
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Brampton, Calgary, Greater Sudbury, Montreal, Québec, Sherbrooke, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Calgary, Guelph, Hamilton, Joliette, Montreal, Stouffville, Surrey, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Hamilton, Moncton, Surrey, Toronto
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleMaridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Where
- Vancouver
- Életkor
- 18 év and over
- People
- 1300 worldwide
- Run by
- Amgen
See details and how to joinNCT07866066 · EU 2025-523772-22-00 - 2. fázisTaking peopleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Brampton, Chicoutimi, Hamilton, Longueuil, Moncton, Sarnia, Toronto, Waterloo
- Életkor
- 18 év to 75 év
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - No phaseTaking peopleOBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders
- Where
- Québec
- Életkor
- 18 év to 80 év
- People
- 42
- Run by
- CHU de Quebec-Universite Laval
See details and how to joinNCT07668661 - No phaseTaking people6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics
- Where
- Kelowna
- Életkor
- 19 év to 64 év
- People
- 20
- Run by
- University of British Columbia
See details and how to joinNCT07676305 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Brampton, Calgary, Guelph, Hamilton, Mississauga, Moncton, Montreal, New Westminster, North York, Québec, Saint-Charles-Borromée, Scarborough Village, Sherbrooke, Stoney Creek, Stouffville, Surrey, Toronto, Truro, Victoria
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 2. fázisNot yet taking people in KanadaAdding Acetazolamide on Top of SGLT2 Inhibition in Persons With Type 2 Diabetes
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 20
- Run by
- University Health Network, Toronto
See details and how to joinNCT07902726 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Calgary, Hamilton, Joliette, Markham, Moncton, Montreal, North York, Québec, Sarnia, Scarborough Village, Stoney Creek, Stouffville, Toronto, Trois-Rivières, Truro, Vancouver
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Guelph, Montreal, Saint-Charles-Borromée, Sarnia, Scarborough Village, Stouffville, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - No phaseTaking peopleTechnology-Enabled Collaborative Care for Diabetes and Mental Health
- Where
- Hamilton, Toronto
- Életkor
- 18 év and over
- People
- 160
- Run by
- McMaster University
See details and how to joinNCT07181863 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Brampton, Calgary, Hamilton, Joliette, Moncton, Montreal, Niagara Falls, North York, Saint-Lambert, Sarnia, Scarborough Village, Stouffville, Terrebonne, Toronto, Truro, Vancouver, Victoria
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 2. fázisTaking peopleEffects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults
- Where
- Montreal
- Életkor
- 40 év to 70 év
- People
- 84
- Run by
- May Faraj, PDt, PhD
See details and how to joinNCT07575438 - 3. fázisTaking peopleCOLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
- Where
- Montreal, Toronto
- Életkor
- 55 év to 80 év
- People
- 10 000 worldwide
- Run by
- Montreal Heart Institute
See details and how to joinNCT05633810 · EU 2024-516646-19-00 - 3. fázisTaking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Where
- Hamilton
- Életkor
- 18 év to 99 év
- People
- 950 worldwide
- Run by
- Amgen
See details and how to joinNCT07684144 · EU 2025-524788-19-00 - 1/2. fázisTaking peopleVV-14300 for the Treatment of Type 1 Diabetes
- Where
- Toronto
- Életkor
- 18 év to 65 év
- People
- 29 worldwide
- Run by
- Kriya Therapeutics, Inc.
See details and how to joinNCT07831798 - No phaseTaking peoplePeel Family Diabetes Prevention Program
- Where
- Brampton
- Életkor
- 14 év and over
- People
- 140
- Run by
- Trillium Health Partners
See details and how to joinNCT07675551 - 3. fázisNot yet taking people in KanadaA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Brampton, Calgary, Guelph, Halifax, Hamilton, Kelowna, London, Moncton, Montreal, Pointe-Claire, Québec, Sarnia, Surrey, Sydney, Toronto, Victoria
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00